...
机译:可逆,口服可用的ADP受体(P2Y(12))拮抗剂第一部分:击中铅工艺
King Saud bin Abdulaziz Univ Hlth Sci Minist Natl Guard Hlth Affairs King Abdullah Int Med Res;
Berlex Biosci Dept Med Chem 2600 Hilltop Dr Richmond CA 94804 USA;
Berlex Biosci Dept Med Chem 2600 Hilltop Dr Richmond CA 94804 USA;
Berlex Biosci Dept Med Chem 2600 Hilltop Dr Richmond CA 94804 USA;
Berlex Biosci Dept Med Chem 2600 Hilltop Dr Richmond CA 94804 USA;
Berlex Biosci Dept Med Chem 2600 Hilltop Dr Richmond CA 94804 USA;
Berlex Biosci Dept Mol Pharmacol 2600 Hilltop Dr Richmond CA 94804 USA;
Berlex Biosci Dept Mol Pharmacol 2600 Hilltop Dr Richmond CA 94804 USA;
Berlex Biosci Dept Mol Pharmacol 2600 Hilltop Dr Richmond CA 94804 USA;
Berlex Biosci Dept Mol Pharmacol 2600 Hilltop Dr Richmond CA 94804 USA;
Berlex Biosci Dept Pharmacol 2600 Hilltop Dr Richmond CA 94804 USA;
Berlex Biosci Dept Pharmacol 2600 Hilltop Dr Richmond CA 94804 USA;
Berlex Biosci Dept Med Chem 2600 Hilltop Dr Richmond CA 94804 USA;
Berlex Biosci Dept Med Chem 2600 Hilltop Dr Richmond CA 94804 USA;
Antiplatelet therapy; ADP; P2Y(12) antagonists; HTS; Parallel synthesis;
机译:可逆,口服可用的ADP受体(P2Y(12))拮抗剂第一部分:击中铅工艺
机译:组织因子加ADP在人富含血小板的血浆中诱导的凝血酶生成:一种潜在的新方法,用于评估口服因子Xa抑制剂edoxaban和P2Y(12)受体拮抗剂同时使用的效果
机译:Ticagrelor:口服可逆P2Y 12受体拮抗剂治疗急性冠状动脉综合征
机译:食用生物学:口服活性肽Bradykinin B1受体拮抗剂用于炎症疼痛治疗
机译:损伤诱导的P2Y受体刺激导致表皮生长因子受体激活和角膜上皮伤口愈合
机译:从新型溶血磷脂中发现ONO-7300243酸性受体1拮抗剂:从命中到领先
机译:AZD6140(一种可逆的口服P2Y12受体拮抗剂)与氯吡格雷相比对急性冠脉综合征患者的血小板聚集抑制作用